COVALENT BINDING OF C3B TO MONOCLONAL-ANTIBODIES SELECTIVELY UP-REGULATES HEAVY-CHAIN EPITOPE RECOGNITION BY T-CELLS

被引:23
作者
SANTORO, L [1 ]
DROUET, C [1 ]
REBOUL, A [1 ]
MACH, JP [1 ]
COLOMB, MG [1 ]
机构
[1] INST BIOCHIM, EPALINGES, SWITZERLAND
关键词
COMPLEMENT; C3; ANTIGEN PRESENTATION;
D O I
10.1002/eji.1830240725
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protein C3 of the complement system is known for its role in the nonspecific immune response. Covalent binding of C3b to antigen upon complement activation also plays a significant role in specific T cell immune response. C3b-antigen complexes can bind to complement receptors on the antigen-presenting cell, and the C3b antigen link (most often an ester link) remains fairly stable inside the cells. In this study, IgG1, kappa and IgG2a, kappa murine monoclonal antibodies (mAb) were used as antigens; covalent complexes between mAb and C3b were produced and purified in vitro from purified proteins; human B cell lines and T cell clones were raised from tumor patients who received mAb injections for cancer therapy or diagnosis. Recognition of epitopes of these mAb by T cell clones when the mAb were processed alone or bound to C3b was compared. IgG or IgG-C3b complexes presented by B cell lines were able to stimulate proliferation of kappa light chain-specific T cell clones at similar concentrations. In contrast, IgG-C3b complex recognition by heavy chain-specific T cell clones required 100-fold less IgG-C3b than uncomplexed IgG. As C3b was shown to be covalently bound only to the IgG heavy chains in the complexes, C3b chaperoning is restricted to only the IgG heavy chain and selectively influences intracellular steps of IgG heavy chain processing. This differential modulation of C3b suggests an early dissociation of IgG heavy and light chains in antigen-presenting cells.
引用
收藏
页码:1620 / 1626
页数:7
相关论文
共 57 条
[1]   STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].
AHEARN, JM ;
FEARON, DT .
ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219
[2]   PURIFICATION OF COMPLEMENT COMPONENTS BY HYDROPHOBIC AFFINITY-CHROMATOGRAPHY ON PHENYL SEPHAROSE - PURIFICATION OF HUMAN C5 [J].
ALSALIHI, A ;
RIPOCHE, J ;
PRUVOST, L ;
FONTAINE, M .
FEBS LETTERS, 1982, 150 (01) :238-242
[3]   EPSTEIN-BARR VIRUS SUSCEPTIBILITY OF NORMAL HUMAN B-LYMPHOCYTE POPULATIONS [J].
AMAN, P ;
EHLINHENRIKSSON, B ;
KLEIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :208-220
[4]   C-3 BINDS COVALENTLY TO THE C-GAMMA-3 DOMAIN OF IGG IMMUNE AGGREGATES DURING COMPLEMENT ACTIVATION BY THE ALTERNATIVE PATHWAY [J].
ANTON, LC ;
ALCOLEA, JM ;
SANCHEZCORRAL, P ;
MARQUES, G ;
SANCHEZ, A ;
VIVANCO, F .
BIOCHEMICAL JOURNAL, 1989, 257 (03) :831-838
[5]  
ANTON LC, 1986, MOL IMMUNOL, V23, P39
[6]  
ARNAOUT MA, 1983, IMMUNOLOGY, V48, P229
[7]  
ARVIEUX J, 1988, IMMUNOLOGY, V65, P229
[8]  
BOTTGER EC, 1987, IMMUNOL TODAY, V8, P261, DOI 10.1016/0167-5699(87)90184-8
[9]   RADIOIMMUNOTHERAPY OF HUMAN-COLON CARCINOMA BY I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN A NUDE-MOUSE MODEL [J].
BUCHEGGER, F ;
VACCA, A ;
CARREL, S ;
SCHREYER, M ;
MACH, JP .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) :127-134
[10]  
CHU CT, 1993, J IMMUNOL, V150, P48